Literature DB >> 23356819

Contributions of molecular properties to drug promiscuity.

Ákos Tarcsay1, György M Keserű.   

Abstract

In contrast to designed polypharmacology that can result in efficient drugs for complex disorders, unintended drug promiscuity has detrimental contribution to side effects and toxicology. Characterization of promiscuous compounds enhances the understanding of complex interaction patterns and aids the design of compounds with broader selectivity against off-targets that has a major impact on medicinal chemistry outcome. In this Miniperspective we provide insights to the effect of physicochemical parameters on promiscuity. Information collected from recent, large-scale in vitro studies enabled us to discuss the relationships between physicochemical properties and promiscuity in detail. In light of these data, lipophilicity and basic character have the highest influence. On the basis of the accumulated knowledge, we propose the extensive use of pre- and postsynthesis metrics, as well as strict control of physicochemical properties during medicinal chemistry optimizations.

Mesh:

Substances:

Year:  2013        PMID: 23356819     DOI: 10.1021/jm301514n

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  23 in total

1.  Discovery of potent 2,4-difluoro-linker poly(ADP-ribose) polymerase 1 inhibitors with enhanced water solubility and in vivo anticancer efficacy.

Authors:  Wen-Hua Chen; Shan-Shan Song; Ming-Hui Qi; Xia-Juan Huan; Ying-Qing Wang; Hualiang Jiang; Jian Ding; Guo-Bin Ren; Ze-Hong Miao; Jian Li
Journal:  Acta Pharmacol Sin       Date:  2017-08-03       Impact factor: 6.150

Review 2.  The tuberculosis drug discovery and development pipeline and emerging drug targets.

Authors:  Khisimuzi Mdluli; Takushi Kaneko; Anna Upton
Journal:  Cold Spring Harb Perspect Med       Date:  2015-01-29       Impact factor: 6.915

3.  Does the Lipid Bilayer Orchestrate Access and Binding of Ligands to Transmembrane Orthosteric/Allosteric Sites of G Protein-Coupled Receptors?

Authors:  Christopher T Szlenk; Jeevan B Gc; Senthil Natesan
Journal:  Mol Pharmacol       Date:  2019-04-08       Impact factor: 4.436

Review 4.  Applications of chemogenomic library screening in drug discovery.

Authors:  Lyn H Jones; Mark E Bunnage
Journal:  Nat Rev Drug Discov       Date:  2017-01-20       Impact factor: 84.694

5.  Decreasing HepG2 Cytotoxicity by Lowering the Lipophilicity of Benzo[d]oxazolephosphinate Ester Utrophin Modulators.

Authors:  Maria Chatzopoulou; Enrico Emer; Cristina Lecci; Jessica A Rowley; Anne-Sophie Casagrande; Lee Moir; Sarah E Squire; Stephen G Davies; Shawn Harriman; Graham M Wynne; Francis X Wilson; Kay E Davies; Angela J Russell
Journal:  ACS Med Chem Lett       Date:  2020-11-04       Impact factor: 4.345

6.  Ligand-based virtual screening identifies a family of selective cannabinoid receptor 2 agonists.

Authors:  Matteo Gianella-Borradori; Ivy Christou; Carole J R Bataille; Rebecca L Cross; Graham M Wynne; David R Greaves; Angela J Russell
Journal:  Bioorg Med Chem       Date:  2014-11-08       Impact factor: 3.641

7.  Structure-guided design of potent diazobenzene inhibitors for the BET bromodomains.

Authors:  Guangtao Zhang; Alexander N Plotnikov; Elena Rusinova; Tong Shen; Keita Morohashi; Jennifer Joshua; Lei Zeng; Shiraz Mujtaba; Michael Ohlmeyer; Ming-Ming Zhou
Journal:  J Med Chem       Date:  2013-11-11       Impact factor: 7.446

8.  Proposed Allosteric Inhibitors Bind to the ATP Site of CK2α.

Authors:  Paul Brear; Darby Ball; Katherine Stott; Sheena D'Arcy; Marko Hyvönen
Journal:  J Med Chem       Date:  2020-10-29       Impact factor: 7.446

9.  Optimization of the Linker Domain in a Dimeric Compound that Degrades an r(CUG) Repeat Expansion in Cells.

Authors:  Raphael I Benhamou; Masahito Abe; Shruti Choudhary; Samantha M Meyer; Alicia J Angelbello; Matthew D Disney
Journal:  J Med Chem       Date:  2020-07-13       Impact factor: 7.446

10.  Structure-guided inhibitor design expands the scope of analog-sensitive kinase technology.

Authors:  Chao Zhang; Michael S Lopez; Arvin C Dar; Eva Ladow; Steven Finkbeiner; Cai-Hong Yun; Michael J Eck; Kevan M Shokat
Journal:  ACS Chem Biol       Date:  2013-07-23       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.